EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

Discordance between CSF amyloid beta and PET‐derived amyloid status and its clinical implications

Gemma Natalie Wright, James Neil Dodds, Rifa Sanjida Punnota, Roberto Vicidomini, Paul Edison

Alzheimer's & Dementia · 2025

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Abstract Background There has been a recent focus within Alzheimer's Disease (AD) research on potential CSF biomarkers as diagnostic tools. PET imaging and CSF biomarkers have been used to determine the amyloid status of individuals when characterising AD. While these measures have largely correlated with each other, it is also suggested that there could be patients who can have discordant results. However, it is still unclear what proportion of AD subjects demonstrate the discordance. Additionally, whether these changes are associated with different pathological and clinical characteristics of the patients. Here, we investigated the discordance between CSF Aβ42:40 and amyloid status and evaluated whether there are any significant changes in their levels of tau aggregation. Method 313 participants’ data were selected from the ADNI database. The cutoff for Aβ42:40 was then calculated using the Youden Index resulting from receiver operating characteristic (ROC) curve. The formula used was J = max c {Se ( c ) + Sp ( c ) − 1}, resulting in a maximum cutoff of J = 0.057 for Aβ42:40. This cutoff produced a discordance rate of 10.5%, with n = 33 of 313 patients being discordant. We then performed t‐tests to investigate the potential clinical differences between concordant and discordant patients. Result Independent samples t‐tests indicated that levels of pTau181 and total Tau significantly differed between the concordant and discordant groups. pTau181 was significantly lower in the discordant group (t(71.2)=‐3.166, p = .002), as was Tau (t(53.9)=‐2.046, p = .046). Further data is found in Figure 1. Conclusion Demonstration of different levels of tau deposition in the discordant groups implies there may be other pathological processes influencing neurodegeneration in these subjects. A discordance of 10% between CSF amyloid and PET amyloid implies that we should evaluate these subjects in greater detail before enrolling them in intervention studies. References 1. Hansson, O. et al. (2019). https://doi.org/10.1186/s13195‐019‐0485‐0 2. Pyun, JM. et al. (2024) https://doi.org/10.1038/s41398‐024‐02766‐6

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Gemma Natalie Wright, James Neil Dodds, Rifa Sanjida Punnota, Roberto Vicidomini, Paul Edison
Quelle
Alzheimer's & Dementia
Publikation
2025-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
1552-5260, 1552-5279
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Gemma Natalie Wright, James Neil Dodds, Rifa Sanjida Punnota, Roberto Vicidomini, Paul Edison (2025). Discordance between CSF amyloid beta and PET‐derived amyloid status and its clinical implications. Alzheimer's & Dementia. https://doi.org/10.1186/s13195-026-02150-0
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1 · Lizenz 2